Ryman Healthcare Limited Stock Probability of Future Pink Sheet Price Finishing Over 8.42
| RHCGF Stock | USD 2.61 0.00 0.00% |
Ryman |
Ryman Healthcare Target Price Odds to finish over 8.42
The tendency of Ryman Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 8.42 or more in 90 days |
| 2.61 | 90 days | 8.42 | close to zero percent |
Based on a normal probability distribution, the odds of Ryman Healthcare to move over $ 8.42 or more in 90 days from now is close to zero percent (This Ryman Healthcare Limited probability density function shows the probability of Ryman Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Ryman Healthcare price to stay between its current price of $ 2.61 and $ 8.42 at the end of the 90-day period is over 95.22 .
Assuming the 90 days horizon Ryman Healthcare Limited has a beta of -0.15 indicating as returns on the benchmark increase, returns on holding Ryman Healthcare are expected to decrease at a much lower rate. During a bear market, however, Ryman Healthcare Limited is likely to outperform the market. Additionally Ryman Healthcare Limited has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Ryman Healthcare Price Density |
| Price |
Predictive Modules for Ryman Healthcare
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ryman Healthcare. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Ryman Healthcare Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Ryman Healthcare is not an exception. The market had few large corrections towards the Ryman Healthcare's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ryman Healthcare Limited, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ryman Healthcare within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.09 | |
β | Beta against Dow Jones | -0.15 | |
σ | Overall volatility | 0.15 | |
Ir | Information ratio | -0.11 |
Ryman Healthcare Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ryman Healthcare for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ryman Healthcare can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Ryman Healthcare generated a negative expected return over the last 90 days | |
| Ryman Healthcare Limited has accumulated 2.58 B in total debt with debt to equity ratio (D/E) of 0.76, which is about average as compared to similar companies. Ryman Healthcare has a current ratio of 0.7, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Ryman Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, Ryman Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ryman Healthcare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ryman to invest in growth at high rates of return. When we think about Ryman Healthcare's use of debt, we should always consider it together with cash and equity. | |
| About 17.0% of Ryman Healthcare outstanding shares are owned by corporate insiders |
Ryman Healthcare Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ryman Pink Sheet often depends not only on the future outlook of the current and potential Ryman Healthcare's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ryman Healthcare's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 500 M | |
| Dividends Paid | 112 M |
Ryman Healthcare Technical Analysis
Ryman Healthcare's future price can be derived by breaking down and analyzing its technical indicators over time. Ryman Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ryman Healthcare Limited. In general, you should focus on analyzing Ryman Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Ryman Healthcare Predictive Forecast Models
Ryman Healthcare's time-series forecasting models is one of many Ryman Healthcare's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ryman Healthcare's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Ryman Healthcare
Checking the ongoing alerts about Ryman Healthcare for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ryman Healthcare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Ryman Healthcare generated a negative expected return over the last 90 days | |
| Ryman Healthcare Limited has accumulated 2.58 B in total debt with debt to equity ratio (D/E) of 0.76, which is about average as compared to similar companies. Ryman Healthcare has a current ratio of 0.7, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Ryman Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, Ryman Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ryman Healthcare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ryman to invest in growth at high rates of return. When we think about Ryman Healthcare's use of debt, we should always consider it together with cash and equity. | |
| About 17.0% of Ryman Healthcare outstanding shares are owned by corporate insiders |
Other Information on Investing in Ryman Pink Sheet
Ryman Healthcare financial ratios help investors to determine whether Ryman Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ryman with respect to the benefits of owning Ryman Healthcare security.